Nathan Eyde

794 total citations
10 papers, 638 citations indexed

About

Nathan Eyde is a scholar working on Physiology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Nathan Eyde has authored 10 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 4 papers in Psychiatry and Mental health and 3 papers in Cognitive Neuroscience. Recurrent topics in Nathan Eyde's work include Migraine and Headache Studies (4 papers), Pain Mechanisms and Treatments (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Nathan Eyde is often cited by papers focused on Migraine and Headache Studies (4 papers), Pain Mechanisms and Treatments (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Nathan Eyde collaborates with scholars based in United States, United Kingdom and Brazil. Nathan Eyde's co-authors include Frank Porreca, Michael H. Ossipov, Tamara King, Jennifer Y. Xie, Howard L. Fields, Edita Navratilova, Alec Okun, Milena De Felice, Chaoling Qu and David W. Dodick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Annals of Neurology.

In The Last Decade

Nathan Eyde

10 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Eyde United States 8 415 266 156 153 103 10 638
Caroline Machado Kopruszinski United States 15 303 0.7× 179 0.7× 260 1.7× 57 0.4× 74 0.7× 38 590
Roberto De Col Germany 13 333 0.8× 195 0.7× 280 1.8× 140 0.9× 111 1.1× 22 705
Liliana L. Luz Portugal 14 287 0.7× 206 0.8× 94 0.6× 63 0.4× 87 0.8× 24 489
Masayoshi Tsuruoka Japan 16 499 1.2× 251 0.9× 47 0.3× 110 0.7× 101 1.0× 45 629
S.S. Mokha United States 21 704 1.7× 582 2.2× 93 0.6× 90 0.6× 239 2.3× 37 1.0k
Chen Yu Chiang Canada 16 547 1.3× 393 1.5× 86 0.6× 138 0.9× 90 0.9× 18 760
Daniel Radzicki United States 8 315 0.8× 230 0.9× 73 0.5× 152 1.0× 122 1.2× 9 642
Kelly J. Powell Canada 11 405 1.0× 487 1.8× 97 0.6× 52 0.3× 256 2.5× 17 770
Raymond Maciewicz United States 11 333 0.8× 277 1.0× 64 0.4× 180 1.2× 147 1.4× 19 711
Lori N. Eidson United States 11 304 0.7× 348 1.3× 66 0.4× 54 0.4× 183 1.8× 14 812

Countries citing papers authored by Nathan Eyde

Since Specialization
Citations

This map shows the geographic impact of Nathan Eyde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Eyde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Eyde more than expected).

Fields of papers citing papers by Nathan Eyde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Eyde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Eyde. The network helps show where Nathan Eyde may publish in the future.

Co-authorship network of co-authors of Nathan Eyde

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Eyde. A scholar is included among the top collaborators of Nathan Eyde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Eyde. Nathan Eyde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Iadonato, Shawn P., et al.. (2023). A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors. Frontiers in Immunology. 14. 1311658–1311658. 19 indexed citations
2.
Guillaudeux, Thierry, Eric J. Tarcha, Nathan Eyde, et al.. (2021). Abstract 1637: A fully human anti-vista antibody as a promising therapy against poorly immunogenic tumors. Cancer Research. 81(13_Supplement). 1637–1637. 3 indexed citations
3.
Iadonato, Shawn P., Eric J. Tarcha, Nathan Eyde, et al.. (2020). 76P Highly potent fully human anti-VISTA antibodies efficiently abrogate the interaction of this new target checkpoint inhibitor to its different putative receptors at different pH. Annals of Oncology. 31. S1448–S1449. 1 indexed citations
5.
Xie, Jennifer Y., Milena De Felice, Caroline Machado Kopruszinski, et al.. (2017). Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. Cephalalgia. 37(8). 780–794. 76 indexed citations
6.
Moutal, Aubin, Nathan Eyde, Ki Duk Park, et al.. (2016). Efficacy of (S)-lacosamide in preclinical models of cephalic pain. PAIN Reports. 1(1). e565–e565. 25 indexed citations
7.
Kopruszinski, Caroline Machado, Jennifer Y. Xie, Nathan Eyde, et al.. (2016). Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents. Cephalalgia. 37(6). 560–570. 55 indexed citations
8.
Felice, Milena De, Nathan Eyde, David W. Dodick, et al.. (2013). Capturing the aversive state of cephalic pain preclinically. Annals of Neurology. 74(2). 257–265. 83 indexed citations
9.
Navratilova, Edita, Jennifer Y. Xie, Alec Okun, et al.. (2012). Pain relief produces negative reinforcement through activation of mesolimbic reward–valuation circuitry. Proceedings of the National Academy of Sciences. 109(50). 20709–20713. 249 indexed citations
10.
Okun, Alec, et al.. (2011). Transient Inflammation-Induced Ongoing Pain is Driven by TRPV1 Sensitive Afferents. Molecular Pain. 7. 4–4. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026